Idera Pharmaceuticals (IDRA)
Idera Pharmaceuticals Historical Price Data
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 25, 2012 | 1.01 | 1.02 | 1.00 | 1.00 | 7319 |
| May 24, 2012 | 1.05 | 1.05 | 1.00 | 1.02 | 7870 |
| May 23, 2012 | 1.00 | 1.07 | 1.00 | 1.02 | 5220 |
| May 22, 2012 | 1.02 | 1.04 | 1.00 | 1.00 | 7726 |
| May 21, 2012 | 1.030 | 1.05 | 1.00 | 1.01 | 10209 |
| May 18, 2012 | 1.03 | 1.11 | 1.026 | 1.03 | 11585 |
| May 17, 2012 | 1.08 | 1.13 | 1.021 | 1.04 | 35599 |
| May 16, 2012 | 1.05 | 1.15 | 1.03 | 1.09 | 25186 |
| May 15, 2012 | 1.02 | 1.06 | 1.02 | 1.06 | 11600 |
| May 14, 2012 | 1.06 | 1.09 | 1.04 | 1.04 | 23633 |
| May 11, 2012 | 1.11 | 1.15 | 1.06 | 1.06 | 31108 |
| May 10, 2012 | 1.100 | 1.16 | 1.10 | 1.10 | 3993 |
| May 9, 2012 | 1.12 | 1.129 | 1.10 | 1.10 | 18867 |
| May 8, 2012 | 1.19 | 1.19 | 1.100 | 1.12 | 33703 |
| May 7, 2012 | 1.16 | 1.20 | 1.081 | 1.19 | 64717 |
| May 4, 2012 | 1.14 | 1.14 | 1.02 | 1.10 | 42675 |
| May 3, 2012 | 1.20 | 1.21 | 1.12 | 1.17 | 79211 |
| May 2, 2012 | 1.37 | 1.37 | 1.18 | 1.19 | 66540 |
| May 1, 2012 | 1.39 | 1.42 | 1.31 | 1.35 | 71524 |
| April 30, 2012 | 1.44 | 1.44 | 1.33 | 1.36 | 76886 |
| April 27, 2012 | 1.48 | 1.48 | 1.420 | 1.46 | 49513 |
| April 26, 2012 | 1.58 | 1.610 | 1.42 | 1.46 | 106161 |
| April 25, 2012 | 1.93 | 1.93 | 1.50 | 1.53 | 152648 |
| April 24, 2012 | 1.81 | 1.96 | 1.80 | 1.92 | 195051 |
| April 23, 2012 | 2.00 | 2.00 | 1.76 | 1.83 | 784257 |
| April 20, 2012 | 2.00 | 2.05 | 1.98 | 2.00 | 71558 |
| April 19, 2012 | 1.97 | 2.08 | 1.90 | 2.00 | 84275 |
| April 18, 2012 | 2.04 | 2.11 | 2.02 | 2.02 | 94511 |
| April 17, 2012 | 2.01 | 2.19 | 2.01 | 2.08 | 198919 |
| April 16, 2012 | 1.89 | 1.99 | 1.80 | 1.98 | 59129 |
| April 13, 2012 | 1.80 | 1.93 | 1.80 | 1.90 | 54100 |
| April 12, 2012 | 1.85 | 1.92 | 1.84 | 1.92 | 49994 |
| April 11, 2012 | 1.84 | 1.90 | 1.84 | 1.87 | 56847 |
| April 10, 2012 | 1.87 | 1.96 | 1.83 | 1.83 | 169934 |
| April 9, 2012 | 1.80 | 1.93 | 1.80 | 1.85 | 60818 |
| April 5, 2012 | 1.70 | 1.75 | 1.65 | 1.74 | 23696 |
| April 4, 2012 | 1.709 | 1.709 | 1.59 | 1.63 | 68998 |
| April 3, 2012 | 1.73 | 1.73 | 1.68 | 1.71 | 10861 |
| April 2, 2012 | 1.73 | 1.75 | 1.653 | 1.70 | 69573 |
| March 30, 2012 | 1.90 | 1.950 | 1.70 | 1.73 | 266479 |
| March 29, 2012 | 1.86 | 2.09 | 1.64 | 1.89 | 441969 |
| March 28, 2012 | 1.50 | 1.53 | 1.48 | 1.530 | 13812 |
| March 27, 2012 | 1.42 | 1.53 | 1.42 | 1.53 | 35190 |
| March 26, 2012 | 1.46 | 1.46 | 1.41 | 1.43 | 31119 |
| March 23, 2012 | 1.42 | 1.42 | 1.42 | 1.42 | 0.00 |
| March 22, 2012 | 1.41 | 1.48 | 1.33 | 1.42 | 16568 |
| March 21, 2012 | 1.45 | 1.50 | 1.41 | 1.43 | 24301 |
| March 20, 2012 | 1.38 | 1.38 | 1.38 | 1.38 | 0.00 |
| March 19, 2012 | 1.35 | 1.480 | 1.33 | 1.37 | 139661 |
| March 16, 2012 | 1.33 | 1.39 | 1.32 | 1.39 | 7731 |
IDRA News
Idera Pharmaceuticals, Inc. (IDRA) Posts Narrower than Expected Q1 Loss
May 09, 7:49AM Street Insider
May 09, 7:49AM Street Insider
Idera Pharmaceuticals Announces Efficacy Data for IMO-8400 in Preclinical Models of Lupus and Psoriasis
May 07, 7:00AM Business Wire
May 07, 7:00AM Business Wire
Idera Pharmaceuticals Announces Presentation of Preclinical Data of IMO-8400 in Both Lupus and Psoriasis Models
May 01, 8:00AM Business Wire
May 01, 8:00AM Business Wire
Idera Pharmaceuticals to Present at the 11th Annual Needham Healthcare Conference
Mar 29, 8:30AM Business Wire
Mar 29, 8:30AM Business Wire
$IDRA http://stks.co/36xd tiny #BIOTECH with a nice round bottom on LT chart - $IDRA
about 63 days ago by LTbioinvestor
about 63 days ago by LTbioinvestor
Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results and Provides Pipeline Update
Mar 14, 8:30AM Business Wire
Mar 14, 8:30AM Business Wire
Idera Pharmaceuticals to Present at Cowen’s 32nd Annual Healthcare Conference
Feb 28, 9:05AM Business Wire
Feb 28, 9:05AM Business Wire
Idera Pharmaceuticals to Present at Cancer Immunotherapy Summit on February 28th
Feb 27, 9:05AM Business Wire
Feb 27, 9:05AM Business Wire
Idera Pharmaceuticals Announces Retirement of Dr. James B. Wyngaarden as a Member of the Board of Directors
Feb 17, 9:05AM Business Wire
Feb 17, 9:05AM Business Wire
$IDRA making a move before BioCEO presentation tomorrow morning. Glad I picked some up cheap last week.
about 106 days ago by illinijill
about 106 days ago by illinijill
$IDRA http://stks.co/2MeF tiny BIO name, chart looks ready for a move, on watch for a possible speculative buy - $IDRA
about 107 days ago by LTbioinvestor
about 107 days ago by LTbioinvestor
CORRECTING and REPLACING Idera Pharmaceuticals to Present at BIO CEO Conference February 13th, 2012
Feb 06, 10:23AM Business Wire
Feb 06, 10:23AM Business Wire
Idera Pharmaceuticals presents positive data on IMO-4200 preclinical models
Dec 13, 4:20PM theflyonthewall.com
Dec 13, 4:20PM theflyonthewall.com
Idera Pharmaceuticals files to sell 8.43M of common stock for holders
Dec 09, 4:16PM theflyonthewall.com
Dec 09, 4:16PM theflyonthewall.com
Idera Pharmaceuticals (IDRA) Receives FDA Approval to Proceed with Phase 2 Trials of IMO-3100
Dec 01, 8:40AM Street Insider
Dec 01, 8:40AM Street Insider
Idera Pharmaceuticals announces FDA authorization for Phase 2 IMO-3100 trial
Dec 01, 8:37AM FlyOnTheWall
Dec 01, 8:37AM FlyOnTheWall
Idera Pharmaceuticals Regains Global Rights to IMO-2055 in Oncology from Merck KGaA
Nov 30, 8:33AM Benzinga
Nov 30, 8:33AM Benzinga
Idera Pharma (IDRA) Reports Encouraging Preclinical Data for Novel GSO Technology
Nov 15, 8:45AM Street Insider
Nov 15, 8:45AM Street Insider
$IDRA great pharma name w/ tremendous potential. Hidden Gem if there ever was 1. Could be a 10-bagger next year same time. Very strong buy
about 260 days ago by pumpndumphunter
about 260 days ago by pumpndumphunter
$IDRA
Idera Reports Clinical Hold on Proposed Phase 2 Clinical Trial of IMO-3100
about 314 days ago by Benzinga
about 314 days ago by Benzinga
Idera Pharma $IDRA reports clinical hold on proposed Phase 2 trial of IMO-3100
about 314 days ago by Street_Insider
about 314 days ago by Street_Insider
Idera $IDRA says Merck won't conduct further development on IMO-2055, will complete ongoing Phase 2 with Erbitux; stock halted
about 328 days ago by Street_Insider
about 328 days ago by Street_Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| IDRA | 1.00 | -0.02 | -1.96% | 27.64M |
| IDN | 1.64 | -0.09 | -5.07% | 47.44M |
| IDIX | 9.41 | -0.27 | -2.79% | 1.041B |
| IDI | 1.85 | -0.03 | -1.60% | 38.59M |
| IDCC | 25.28 | +0.14 | +0.56% | 1.134B |
| IDA | 39.30 | +0.17 | +0.43% | 1.955B |
| ICUI | 52.22 | +0.21 | +0.40% | 722.94M |
| ICS | 15.36 | +0.07 | +0.46% | |
| ICON | 15.86 | +0.38 | +2.45% | 1.123B |
| ICLR | 21.90 | -0.03 | -0.14% | 1.319B |